CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 52.95
-1.78 (-3.25%)
Jul 22, 2025, 1:45 PM CST
CSPC Innovation Pharmaceutical Company Description
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.
It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China.
CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 2,487 |
| CEO | Bing Yao |
Contact Details
Address: No. 62 Zhangju Road Shijiazhuang, 051430 China | |
| Phone | 86 311 6780 9843 |
| Website | xnwpharma.net |
Stock Details
| Ticker Symbol | 300765 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003K04 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Bing Yao | GM and Executive Chairman |
| Long Dai | Secretary, Chief Financial Officer and Director |